High periostin levels have been associated with more severe asthma phenotypes, an increased risk of exacerbations, and poorer responses to standard asthma therapies, highlighting its potential utility in guiding treatment decisions, particularly the use of biologic therapies addressing eosinophilic inflammation [22,29]. Here, POSTN is linked to asthma.